Skip to main content

Written question asked by John Milne (Liberal Democrat) on Monday, 13 July 2026, in the House of Commons. It was due for an answer on Thursday, 16 July 2026 (named day). It was answered by Preet Kaur Gill (Labour) on Thursday, 16 July 2026 on behalf of the Department of Health and Social Care.


National Institute for Health and Care Research: Clinical Trials

Question

To ask the Secretary of State for Health and Social Care, how many people were recruited into National Institute for Health and Care Research supported (i) phase 1, (ii) phase 2, and (iii) phase 3 trials for (a) dementia, (b) cancer, (c) stroke and (d) coronary heart disease for each year from 2020/21 to 2024/25.

Answer

The UK Clinical Research Delivery key performance indicators (UKCRD KPI) report monitors the United Kingdom’s delivery of globally competitive clinical research. The table attached provides the requested figures for phase 1, phase 2, and phase 3 interventional clinical trials, by disease type.

They are an unpublished subset of statistics under indicator six of the UKCRD KPI report, which measures the number of participants recruited to clinical studies. The information is taken from studies recorded on the National Institute for Health and Care Research (NIHR) Research Delivery Network’s (RDN) Central Portfolio Management System.

The data was processed and assured by the NIHR RDN’s data, analytics, and specialty teams using the same established checks applied to data provided to the Department for publication in the UKCRD KPI report.


Secondary information

Type
Written question
Reference
18467
Session
2026-27
Attachment
Additional Document
Subjects
Cancer Dementia Heart diseases Strokes Clinical trials National Institute for Health and Care Research
Contains statistics
Yes
Link
View this Written question on www.parliament.uk